Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

263
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
263
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

196
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
196
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

214
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
214
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

522
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
522
Multiple Allele Traits01:49

Multiple Allele Traits

38.0K
The Concept of Multiple Allelism
38.0K
Levels of Organization01:09

Levels of Organization

138.8K
Biological organization is the classification of biological structures, ranging from atoms at the bottom of the hierarchy to the Earth's biosphere. Each level of the hierarchy represents an increase in complexity that builds upon the previous level.
Molecules Are Composed of Atoms, and Biomolecules Are Assembled from Molecules:
The most basic levels include atoms, molecules, and biomolecules. Atoms, the smallest unit of ordinary matter, are composed of a nucleus and electrons. Molecules...
138.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Artificial intelligence solution to accelerate the acquisition of MRI images: Impact on the therapeutic care in oncology in radiology and radiotherapy departments.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2024
Same author

Postoperative radiotherapy after flap reconstructive surgery in patients with head and neck cancer: A retrospective monocentric study with flap delineation to assess toxicity and relapse.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2020
Same author

Biopsychosocial determinants of visuospatial memory performance according to different spaces.

Neuroscience research·2020
Same author

[MRI can be prescribed in patients with implanted cardiac devices (pacemaker, defibrillator) to optimize radiotherapy planning].

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2020
Same author

Hypofractionated stereotactic radiotherapy for challenging brain metastases using 36 Gy in six fractions.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2019
Same author

A randomized, double-blind, placebo-controlled trial on the efficacy of tranexamic acid combined with rivaroxaban thromboprophylaxis in reducing blood loss after primary cementless total hip arthroplasty.

The bone & joint journal·2019

Related Experiment Video

Updated: Jan 21, 2026

A Data-Driven Approach to Quantifying Immune States in Sepsis
07:42

A Data-Driven Approach to Quantifying Immune States in Sepsis

Published on: February 7, 2025

485

Pediatric sepsis and multiple organ dysfunction syndrome.

O Despond1, F Proulx, J A Carcillo

  • 1Division of Pediatric Intensive Care, Department of Pediatrics, Sainte-Justine Hospital, Université de Montréal, Montréal, Canada.

Current Opinion in Pediatrics
|June 5, 2001
PubMed
Summary

Systemic inflammatory response syndrome (SIRS) and sepsis involve complex cytokine signaling. Current therapies for sepsis and multiple organ dysfunction syndrome remain primarily supportive.

More Related Videos

Author Spotlight: Advanced Integrated Model for Sepsis-Induced Myopathy and Single-Cell Metabolic Analysis
04:01

Author Spotlight: Advanced Integrated Model for Sepsis-Induced Myopathy and Single-Cell Metabolic Analysis

Published on: June 14, 2024

1.4K
A Controlled Mouse Model for Neonatal Polymicrobial Sepsis
14:54

A Controlled Mouse Model for Neonatal Polymicrobial Sepsis

Published on: January 27, 2019

11.7K

Related Experiment Videos

Last Updated: Jan 21, 2026

A Data-Driven Approach to Quantifying Immune States in Sepsis
07:42

A Data-Driven Approach to Quantifying Immune States in Sepsis

Published on: February 7, 2025

485
Author Spotlight: Advanced Integrated Model for Sepsis-Induced Myopathy and Single-Cell Metabolic Analysis
04:01

Author Spotlight: Advanced Integrated Model for Sepsis-Induced Myopathy and Single-Cell Metabolic Analysis

Published on: June 14, 2024

1.4K
A Controlled Mouse Model for Neonatal Polymicrobial Sepsis
14:54

A Controlled Mouse Model for Neonatal Polymicrobial Sepsis

Published on: January 27, 2019

11.7K

Area of Science:

  • Critical care medicine
  • Immunology
  • Pathophysiology

Background:

  • Systemic inflammatory response syndrome (SIRS) is the body's systemic response to inflammatory mediators.
  • Sepsis is defined as SIRS caused by infection, potentially leading to multiple organ dysfunction syndrome (MODS).
  • The pathophysiology involves complex interactions of cellular and molecular mediators.

Purpose of the Study:

  • To review the pathophysiology of SIRS, sepsis, and MODS.
  • To discuss current and emerging therapeutic strategies.
  • To highlight the complexity of these conditions.

Main Methods:

  • Literature review of pathophysiologic mechanisms.
  • Discussion of cellular and molecular mediators.
  • Overview of recent therapeutic investigations.

Main Results:

  • SIRS involves dysregulated cytokine signaling.
  • Pathophysiology may include loss of autoregulation, microcirculatory issues, and apoptosis.
  • Novel treatments like immune-modulating diets and molecular immunomodulation require further evaluation.

Conclusions:

  • Sepsis and MODS are severe conditions with complex underlying mechanisms.
  • Current treatment for sepsis and MODS is largely supportive.
  • Further research is needed to evaluate new therapeutic approaches.